BackNatera Overview

Natera Receivables

Track Natera's receivables ($420M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$421.97M
↑ 36.46% YoYΔ $112.74M vs prior year quarter

Peer trimmed avg / median

Loading

Natera Receivables History

Loading

Natera vs. peers: Receivables Comparison

Loading

Natera Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Natera (NTRA) FAQ

Natera (NTRA) currently reports a receivables of $420M as of June 2026. That compares with $310M in the prior-year period — up 36.5% year over year. Use the charts on this page to explore Natera's receivables history and peer comparisons.

Natera's receivables increased from $310M to $420M — a 36.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Natera reported $420M in receivables as of June 2026. That compares with $310M in the prior-year period — up 36.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $420M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Natera, and consider following NTRA for alerts when major investors trade the stock.

Natera is classified in the Healthcare sector. On receivables, it currently shows $420M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NTRA with unrelated industries.